TRADEMARK OF THE WEEK – ELIOS

ExSight Ventures has put money into ELT Sight, Inc., a company whose next-generation ELIOS trademark procedure is used for safe and effective micro-invasive glaucoma surgery. With the money, the company will be able to do a clinical trial for the FDA in the US. People with glaucoma can lower their eye pressure with the new ELIOSTM excimer laser system from ELT. This system uses an excimer laser and has been given a CE mark in Europe.

The ELIOSTM system is a new way to do minimally invasive glaucoma surgery (MIGS) that has a lot of advantages over what is already available. The Glaucoma Research Foundation thinks that 111 million people will have glaucoma by the year 2040. MIGS has changed the way that people with uncontrolled IOP are treated and cared for. EV’s investment in ELT is unique because its technology has been proven in clinical trials and it has a great team of ophthalmologists and clinical advisors.

ELT Sight, Inc. CORPORATION company registered the brand “ELIOS” on 17^th August 2021 bearing the serial number 90080256. It is a mark registered as a trademark and service mark falling under class 010 of the International Classification of Goods and Services bearing registration no.6457542.